[
  {
    "ts": null,
    "headline": "BVS Stock Gains Post Divestiture of Advanced Rehabilitation Business",
    "summary": "Bioventus aims to improve its focus and execution within its core businesses and enhance liquidity following the divestiture.",
    "url": "https://finnhub.io/api/news?id=8b3464b7f2d259216dcda2c08b44b2e1b1068f164e3d9df2c16bd102873eee86",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1735919580,
      "headline": "BVS Stock Gains Post Divestiture of Advanced Rehabilitation Business",
      "id": 132255244,
      "image": "https://media.zenfs.com/en/zacks.com/b35c1538fbd501bfb8e20b349661fde7",
      "related": "CAH",
      "source": "Yahoo",
      "summary": "Bioventus aims to improve its focus and execution within its core businesses and enhance liquidity following the divestiture.",
      "url": "https://finnhub.io/api/news?id=8b3464b7f2d259216dcda2c08b44b2e1b1068f164e3d9df2c16bd102873eee86"
    }
  },
  {
    "ts": null,
    "headline": "Reasons to Add Cardinal Health Stock to Your Portfolio Now",
    "summary": "CAH continues to grow on the back of its robust product portfolio and a strong quarterly result.",
    "url": "https://finnhub.io/api/news?id=cf22f6e5f5b23b2b3571ee58cac7afe5fdf6417f7e2575e34c216003b950e1ab",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1735914240,
      "headline": "Reasons to Add Cardinal Health Stock to Your Portfolio Now",
      "id": 132258837,
      "image": "https://media.zenfs.com/en/zacks.com/181d5ab1675d8aae9c53428215552644",
      "related": "CAH",
      "source": "Yahoo",
      "summary": "CAH continues to grow on the back of its robust product portfolio and a strong quarterly result.",
      "url": "https://finnhub.io/api/news?id=cf22f6e5f5b23b2b3571ee58cac7afe5fdf6417f7e2575e34c216003b950e1ab"
    }
  },
  {
    "ts": null,
    "headline": "Reasons to Retain Inari Medical Stock in Your Portfolio for Now",
    "summary": "NARI continues to gain from its expanded product portfolio. The company's expansion in China and Japan bodes well.",
    "url": "https://finnhub.io/api/news?id=ac0e1afb6fcc8bae5400e22dd8fbd98de23c5a166702ee2d2dd1530a92d0b600",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1735910880,
      "headline": "Reasons to Retain Inari Medical Stock in Your Portfolio for Now",
      "id": 132253903,
      "image": "https://media.zenfs.com/en/zacks.com/b66321e586fa6fdc44309f696ff0a17a",
      "related": "CAH",
      "source": "Yahoo",
      "summary": "NARI continues to gain from its expanded product portfolio. The company's expansion in China and Japan bodes well.",
      "url": "https://finnhub.io/api/news?id=ac0e1afb6fcc8bae5400e22dd8fbd98de23c5a166702ee2d2dd1530a92d0b600"
    }
  }
]